Insight

Jun 12, 2024, 11:04

Iván R. González on a paper by Marjorie E. Zettler

Iván R. González, Medical Oncologist at Comprehensive Oncology Center, Hospital Ángeles Puebla, shared a post on X:

“Optimizing cancer therapy dosages is essential!

Targeted therapies have slashed cancer mortality and set a new standard, but traditional dosing methods lag behind. The FDA’s Project Optimus and new guidelines aim to fix this. Reshaping pre-approval dosing and continuous research will maximize patient benefits and minimize avoidable toxicity.

Future incentives for post-market dose optimization could be a game-changer.”

Read further
Source: Iván R. González/X

cancer cancer therapy Comprehensive Oncology Center dose optimization FDA Hospital Ángeles Puebla Iván R. González Marjorie E. Zettler OncoDaily Oncology Project Optimus targeted therapy

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage